Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on March 31, 2024, to cover tax obligations.
Summary
- On March 31, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
- The transaction was executed to cover tax obligations related to previously acquired shares.
- Following the transaction, Christianson directly owns 325,234 shares of NeuroOne Medical Technologies Corp.
- The shares were disposed of at a price of $1.2.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's overall outlook.
Industry Context
Form 4 filings are a routine part of compliance for publicly traded companies, providing transparency into insider transactions and ensuring fair market practices.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: disposal of shares. |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.